PetMedix

📍 Cambridge, United Kingdom🗓 Founded 2017👥 43 employees💰 Last funded May 2020
Biotechnology Research🌐 petmedix.co.uk
Website LinkedIn
PetMedix is a development stage veterinary biopharmaceutical company based in Cambridge, UK. We are using the highest quality science to make the therapies our pets need and deserve, keeping them healthier, happier, and for longer. Building on more than thirty years of world-leading innovation and human drug development, we are applying the cutting edge of science to bring breakthroughs for the animals we love and care for. PetMedix is taking the experience of its founding team, and decades of human clinical research, to build platforms that generate fully species-specific, naturally-generated therapeutic antibodies. These platforms have been designed to generate a repertoire of antibodies as diverse as the companion animal immune systems on which they are based. These platforms can then be used to develop a broad pipeline of our own veterinary medicines to target under-served clinical areas that represent excellent market opportunities. We are actively recruiting so please get in touch if you wish to join our hard-working and talented team.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in PetMedix?
PetMedix has 1 investors on record on gritt.io, 1 mid-stage.
When did PetMedix last raise funding?
The most recent investment in PetMedix recorded on gritt.io was in May 2020.
When was PetMedix founded?
PetMedix was founded in 2017.
What industry is PetMedix in?
PetMedix operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is PetMedix based?
PetMedix is headquartered in Cambridge, United Kingdom.